genetic aberrations involved in the multistep oncogenesis of human multiple myeloma (MM). [1] [2] [3] In particular, the importance of the chromosomal translocations involving immunoglobulin (Ig) gene loci, such as IgH on 14q32 (14q+ chromosome) and Igλ on 22q11, has been well documented. [1] [2] [3] [4] Consequently, the specific protooncogenes located at donor chromosomal loci such as 11q13, 8q24, 6p25, 4p16 and 16q24, harboring respectively the CyclinD1, c-MYC, MUM1, FGFR3 and c-MAF genes, are deregulated by the effect of regulatory elements of the Ig genes. 2, 3, [5] [6] [7] [8] [9] [10] Each chromosomal translocation seems to have a distinct role in the development of MM. For instance, t(11;14)(q13;q32) arises during the early phase of plasma cell dyscrasia, which is clinically represented by monoclonal gammopathy of undetermined significance (MGUS), in contrast to t(8;14)(q24;q32) and t(4;14)(p16;q32), which are assumed to accelerate the progression from MGUS through MM. 11, 12) However, not all of the responsible genes activated on the 14q+ chromosomes in MM have been identified. This prompted us to focus on the remaining partner chromosomes of the IgH loci in an attempt to ascertain new elements associated with MM development. This is the first report to clarify, by means of fluorescence in situ hybridization (FISH) analysis, the detailed locations of the two 20q11 breakpoints involved in t(14;20)(q32;q11). We also found that this specific genetic alteration resulted in an ectopic expression of the MAFB protooncogene, which is a member of the MAF family basic region/leucine zipper transcription factor and is located at 450-680 kb telomeric to one of the breakpoints, probably due to the influence of the 3′α enhancers of the IgH gene.
MATERIALS AND METHODS
A total of 16 MM cell lines (U266, SK-MM-1, ODA,  AMO1, NCU-MM-1, XG-7, FR4, NOP-1, KM-4, KM-5,  KM-7, SACHI, JJN3, ILKM-2, ILKM-3 and ILKM-8) were used. 7, 9, 13) These cell lines have been characterized previously except for SACHI, which was established from the pericardial fluid of a 47-year-old female patient with plasma cell leukemia (PCL) generating IgG-λ type M-protein. G-Banding analysis revealed its complex karyotype featuring hyperdiploidy with 14q+ chromosomes. FISH analysis of the SACHI cells identified the donor chromosomes of the IgH loci as 8q24 and 20q11 loci (Taniwaki et al., unpublished observation). The presence of t(14;20)(q32;q11) in SK-MM-1 was demonstrated by spectral karyotyping analysis. 1) Twenty-two patients with MM, whose percentage of tumor cells exceeded 13.6% of the total nucleated cells in bone marrow aspirates, were included in this study after their informed consent had been obtained.
Information for yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs) and P1 artificial chromosomes (PACs) mapped to the 20q11 locus was obtained through the homepages of the MIT Whitehead Institute (http://www-genome.wi.mit.edu/) and the Sanger Centre Human Genome Data Base (http:// www.sanger.ac.uk/HGP/Chr20). The CEPH YACs were purchased from Research Genetics Inc. (Huntsville, AL) and their contig was constructed on the basis of the presence or absence of the distinct STS markers. The PAC contig was constructed according to the sequence overlap and on the basis of hybridization results with PAC-end probes prepared with the bubble-PCR method when sequence data were not available. 14) Chromosome preparation for DCFISH analyses has been described previously. 4, 9, 10) Each PAC/BAC/YAC DNA itself was labeled with either Spectrum Orange or Spectrum Green using a nick translation kit (Vysis Inc., purchased from Fujisawa Pharmaceutical Co., Osaka) according to the manufacturer's instruction. BAC417P24 DNA purchased from BAC/PAC Resources (Oakland, CA) was used as a probe derived from the IgH constant region at the 14q32 locus. To determine the chromosomal loci of specific signals on the metaphase spreads, we used whole chromosome painting (WCP) probes which could detect chromosomes 2, 14, 20 and 22 (Vysis) when needed. Hybridization and washing protocols were the same as those available from the company (Vysis) on the internet. Each slide was counterstained with 4′,6-diamino-2-phenylindole dihydrochloride (DAPI). For the interphase DCFISH used for the patient marrow samples, signals containing PAC644L1/BAC417P24 fusions were evaluated in 100 nuclei per slide. The cut-off index to assess fusion signals was determined by evaluating peripheral blood mononuclear cell samples derived from five normal volunteers.
Northern blot analysis was performed as described previously. 7, 14) Total RNA was isolated with the guanidine isothiocyanate/cesium chloride ultracentrifugation method. Human MAFB probes were amplified from the PAC RPCI4-644L1 by PCR, as this gene has no intron, by using a primer pair, F5′ (5′-GACCGCTTCTCCGACGACCA-3′) and R6′ (5′-CCCTCTCGCTCAAGTCAAAC-3′), whose sequences were reported by Wang et al. 15) The size of the probe was 479 bp. Expressed sequenced tag (EST) clones, mapped telomeric to SACHI's breakpoint, were purchased from Research Genetics Inc. and their inserts were used as probes. The quality and amount of each RNA were assessed by subsequent hybridization with β-ACTIN probe.
RESULTS AND DISCUSSION
The chromosome 20q11 locus is known to be rearranged or deleted in various types of human malignancies. It has attracted the attention mainly of hematologists because a region extending from 20q11.2 to 20q12 is commonly deleted in myeloid leukemias, suggesting the existence of an as yet unidentified tumor suppressor gene within this region. [15] [16] [17] Accordingly, YAC contigs have already been constructed by several groups and were available when we focused on t(14;20), which is occasionally encountered in human MM. In order to determine the approximate locations of the 20q11 breakpoints of SK-MM-1 and SACHI cell lines, we decided to use DCFISH analysis. In brief, two Mega-YACs' DNAs located between loci D20S884 and D20S96 were labeled (Fig.  1A) , one with Spectrum Green and the other with Spectrum Orange, and hybridized to metaphase spreads of the two cell lines. When the green and red signals were split onto different chromosomes, we could determine the locations of the breakpoints between the two YACs, which were used as probes. This strategy resulted in the eventual confirmation of SK-MM-1's breakpoint within y953C12 itself and that of SACHI between y953C12 and y808C5 ( Fig. 1, A, B and Fig. 2, A, B) . These YACs were then mapped at the 20q11.2-12 locus. To narrow down the breakpoints, PAC/BAC contigs encompassing the region between the D20S174 and PLC1 gene loci, whose locations were mapped to centromeric and telomeric ends of y953C12 and y808C5, respectively, were constructed based on the sequence information provided by Sanger Centre Human Genome Data Base. As for the PAC/BAC clones whose complete sequences were not available, we confirmed each overlap by means of Southern hybridization analyses using PAC/BAC-end probes obtained with the bubble-PCR method, 9) shown as open circles in Fig. 1 . Further FISH analyses using PAC/BAC probes could narrow down the locations of these two breakpoints to within PACs 600E6 for SK-MM-1 and 191L6 for SACHI cells, as shown in Fig. 1 . This means that the distance between the breakpoints was no more than 680 kb (460-680 kb), as estimated from the PAC/BAC data with respect to size and sequence.
In an attempt to make sure that these 20q11 breakpoints were juxtaposed to the IgH gene at the chromosome 14q32 locus as a result of t(14;20), we next employed DCFISH using either y808C5 or PAC644L1, which were mapped telomeric to SACHI's breakpoint, and BAC417P24 probes spanning the IgH constant region at 14q32, as shown in Fig. 2C . The reason for this strategy was that the protooncogenes, dysregulated by the 3′α enhancers of IgH as a result of the presence of 14q+ chromosomes in MM, were reported generally to be located telomeric to chromosomal breakpoints. 2, 3) In SK-MM-1 cells, signals derived from y808C5/PAC644L1 moved to chromosome 14q32 and fused to BAC417P24, indicating that the telomeric tip to its breakpoint at 20q11 was juxtaposed to the constant region of the IgH gene (Fig. 2D) . In a SACHI cell, two fused signals between y808C5/PAC644L1 and BAC417P24 were observed in a metaphase spread, while they were mapped onto two marker chromosomes, whose derivations originated from neither chromosome 14 nor 20 (Fig. 2E) .
Since the IgH 3′α enhancer has been reported to influence the transcription of specific protooncogenes over sev- eral hundred kilobases in MM cells, 2, 5, 18) we hypothesized the presence of the common target protooncogene(s) in these two cell lines, specifically at a location telomeric to the 20q11 breakpoints. We then surveyed transcripts mapped telomeric to the breakpoints of both cell lines at the 20q11 locus according to the sequence data and gene profile of the PAC/BAC clones obtained from the Sanger Centre Human Genome Data Base in addition to the exon trapping analyses of PAC155H19, whose genomic sequences had not been fully completed. This region showed a relatively low gene density. Only three ESTs and two known genes, BPI (bactericidal/permeability-increasing protein) and MAFB, have been reported between the SACHI's breakpoint and PAC644L1, which are located at no more than 800 kb downstream to the breakpoint, as shown in Fig. 1 . For the purpose of identifying candidate gene(s) dysregulated by t(14;20), we examined the expression of each of their cDNAs by means of northern blot analyses of MM cell lines including SK-MM-1 and SACHI cells. The mRNA expression of ESTs R98337, SG53189 and BPI was not detected in the MM cell lines we used (data not shown). This was supposed to be due to either the high fidelity of promoter functions, which were shut down in the plasma cell stage, or the low sensitivity of our northern analyses. But, EST SG30600 was expressed as a 4.0 kb message at similar levels in all MM cell lines, as well as in various hematopoietic cell lines including those consistent with the mature B cell stage (data not shown). Interestingly, the MAFB gene mapped at 450-680 kb telomeric to the SACHI's breakpoint was expressed in both SK-MM-1 and SACHI cells (Fig. 3) . In our panel of 16 MM cell lines, three cell lines, SK-MM-1, SACHI and KM-5, expressed 3.0 kb transcripts as shown in Fig. 3A (some data omitted) . In particular, remarkable overexpression of both 3.0 kb mRNA and 1.8 kb mRNA of an alternatively transcribed form was observed in the SACHI cells when compared to that in SK-MM-1 and KM-5. Since the expression of the MAFB gene is restricted to immature myeloid/monocytic lineages in hematopoietic cells, mRNA expression in these three MM cell lines is ectopic. 15, 19, 20) We also analyzed various hematopoietic cell lines including B-lymphoid lines, ranging from pro-B to mature B cell stages, for MAFB expression, but no expression was seen (Fig. 3B) . We next attempted to clarify by means of DCFISH analyses the mechanisms underlying the ectopic MAFB expression in KM-5 cells. However, the MAFB locus did not fuse to any other Ig gene loci, including the IgH, Igλ and Igκ loci, in this cell line, nor could any amplification of the gene be found when Southern blot analysis was used (data not shown), so the responsible mechanism in this cell line remains to be clarified.
At present, we cannot exclude the possibility of other target gene(s) existing besides MAFB, because the ectopic 21) Like other large MAF proteins such as c-MAF involved in MM with t(14;16), 8) it has both a carboxy-terminal bZip domain, which mediates DNA binding and dimer formation, and an amino-terminal acidic domain associated with transactivating capability. 15, 21) MAFB proteins have dual functions in the transcription of downstream genes and whether they function as transactivator or transrepressor depends on the target sequences of MAF-responsive elements (MARE) and the interacting proteins, such as c-Fos and Ets-1. MAFB seems to be ubiquitously expressed in various tissues, while its expression in hematopoietic cells is restricted to myelomonocytic lineage and macrophages. It has recently been demonstrated to play crucial roles in the proliferation of myelomonocytic progenitors and subsequently the promotion of differentiation into the monocytic lineage, and in the prevention of erythroid differentiation in myeloid progenitors. 19, 20) Although we have not yet fully sequenced the MAFB cDNAs derived from SK-MM-1 and SACHI cells, transcripts with aberrant sizes were not observed, at least in northern analysis. However, wild-type MAFB itself has been shown to transform chicken embryonic fibroblasts when it is artificially overexpressed, 21) indicating that it acts as an oncogene under certain circumstances. We conclude that the ectopic MAFB expression in plasma cells as a result of t(14;20) may disturb physiological process of proliferation and differentiation of B lymphocytes, depending on the presence of interacting proteins, and may eventually lead to unlimited proliferation. In our experiments, it has been difficult to find any correlation between expression level of the MAFB gene in three MM cell lines and specific malignant phenotypes, because these cell lines carry not only t(14;20) but also other 14q+ chromosomes, which lead to the deregulated expression of various protooncogenes such as c-MYC and MUM1. 7) Accordingly, the effect of MAFB expression in B cell lineage remains to be clarified through further transfection and transgenic studies.
By means of DCFISH using PAC644L1 and BAC417P24 probes, we further explored the frequency of the fusion between MAFB and IgH loci in human MM. ated in controls accounted for 7.40±2.07% (mean±1 SD). Of the 22 cases analyzed, none possessed MAFB/IgH fusions in statistically significant fractions (> mean+3 SD) of the total nuclei. Accordingly, t(14;20) seems to be a nonrandom but relatively rare chromosomal alteration in human MM, although further studies covering a large number of MM cases are need to clarify the significance of this alteration, especially in association with clinical and biological behaviors, as it has been suggested that some specific 14q+ markers may be relevant to certain clinical phenotypes. 2, 3, 10) 
